Pages that link to "Q36763078"
Jump to navigation
Jump to search
The following pages link to Expert opinion: omega-3 fatty acids and bleeding-cause for concern? (Q36763078):
Displaying 50 items.
- The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease (Q24613094) (← links)
- Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature (Q24619357) (← links)
- The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia (Q26738554) (← links)
- Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus (Q26752919) (← links)
- Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation (Q28066354) (← links)
- A Comparative Overview of Prescription Omega-3 Fatty Acid Products (Q28972330) (← links)
- The muscle mass, omega-3, diet, exercise and lifestyle (MODEL) study - a randomised controlled trial for women who have completed breast cancer treatment. (Q33552584) (← links)
- Omega-3 fatty acids and cognitive function in women (Q33677382) (← links)
- The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin (Q34080568) (← links)
- Phase 1 study of the effect of icosapent ethyl on warfarin pharmacokinetic and anticoagulation parameters (Q34416861) (← links)
- Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease. (Q34418028) (← links)
- The physician's unique role in preventing violence: a neglected opportunity? (Q34487342) (← links)
- Commonly Used Dietary Supplements on Coagulation Function during Surgery (Q34517159) (← links)
- Omega-3 fatty acids modulate collagen signaling in human platelets (Q34543177) (← links)
- Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia (Q34583622) (← links)
- Fish oil in primary and secondary cardiovascular prevention (Q34986662) (← links)
- The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA. (Q35395358) (← links)
- Fish oil for the treatment of cardiovascular disease. (Q35552231) (← links)
- The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patients (Q35809593) (← links)
- Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction (Q36081403) (← links)
- Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression (Q36327782) (← links)
- Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects (Q36423040) (← links)
- Omega-3 Fatty acids and vitamin d in cardiology (Q36546551) (← links)
- Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation (Q36592844) (← links)
- The combination of EPA DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans. (Q36659192) (← links)
- Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice. (Q36773267) (← links)
- Risk management of nutritional supplements in chronic illness: the implications for the care of cancer and depression. (Q36981770) (← links)
- A fish a day, keeps the cardiologist away! - A review of the effect of omega-3 fatty acids in the cardiovascular system (Q37015975) (← links)
- Pediatric Integrative Medicine Approaches to Attention Deficit Hyperactivity Disorder (ADHD) (Q37055817) (← links)
- Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications (Q37104877) (← links)
- New evidence for the cardiovascular benefits of long chain omega-3 fatty acids (Q37123712) (← links)
- Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia (Q37142087) (← links)
- Dispelling the myths about omega-3 fatty acids (Q37226404) (← links)
- Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. (Q37244564) (← links)
- Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients (Q37248784) (← links)
- Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia (Q37507934) (← links)
- Fish oil diet associated with acute reperfusion related hemorrhage, and with reduced stroke-related sickness behaviors and motor impairment. (Q37586350) (← links)
- Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA) (Q37615904) (← links)
- Essential fatty acids in the treatment of dry eye. (Q37682316) (← links)
- Effect of omega-3 fish oil on cardiovascular risk in diabetes. (Q37763811) (← links)
- The dental patient on oral anticoagulant medication: a literature review (Q37809106) (← links)
- Complementary and alternative medicine for the treatment of major depressive disorder (Q37889534) (← links)
- Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literature (Q38000190) (← links)
- Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. (Q38025713) (← links)
- Review and clinical update on parenteral nutrition-associated liver disease. (Q38054057) (← links)
- Omega-3 polyunsaturated fatty acids for major depressive disorder (Q38148244) (← links)
- Long-chain omega-3 fatty acids: time to establish a dietary reference intake (Q38151841) (← links)
- Icosapent ethyl for treatment of elevated triglyceride levels (Q38164650) (← links)
- Polyunsaturated fatty acids in emerging psychosis: a safer alternative? (Q38214798) (← links)
- Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors (Q38233967) (← links)